Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVs.

Pinto-Espinoza C, Guillou C, Rissiek B, Wilmes M, Javidi E, Schwarz N, Junge M, Haag F, Liaukouskaya N, Wanner N, Nicke A, Stortelers C, Tan YV, Adriouch S, Magnus T, Koch-Nolte F.

Open source

DOI
10.3389/fphar.2022.1029236
Published
2022-10-10
Container
Front Pharmacol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2022.1029236,
  title = {Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVs.},
  author = {Pinto-Espinoza C and  Guillou C and  Rissiek B and  Wilmes M and  Javidi E and  Schwarz N and  Junge M and  Haag F and  Liaukouskaya N and  Wanner N and  Nicke A and  Stortelers C and  Tan YV and  Adriouch S and  Magnus T and  Koch-Nolte F.},
  year = {2022},
  journal = {Front Pharmacol},
  doi = {10.3389/fphar.2022.1029236},
  url = {https://doi.org/10.3389/fphar.2022.1029236}
}

RIS

TY  - JOUR
TI  - Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVs.
AU  - Pinto-Espinoza C
AU  -  Guillou C
AU  -  Rissiek B
AU  -  Wilmes M
AU  -  Javidi E
AU  -  Schwarz N
AU  -  Junge M
AU  -  Haag F
AU  -  Liaukouskaya N
AU  -  Wanner N
AU  -  Nicke A
AU  -  Stortelers C
AU  -  Tan YV
AU  -  Adriouch S
AU  -  Magnus T
AU  -  Koch-Nolte F.
PY  - 2022
JO  - Front Pharmacol
DO  - 10.3389/fphar.2022.1029236
UR  - https://doi.org/10.3389/fphar.2022.1029236
ER  - 

APA

C, P., C, G., B, R., M, W., E, J., N, S., M, J., F, H., N, L., N, W., A, N., C, S., YV, T., S, A., T, M., & F., K. (2022). Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVs.. Front Pharmacol. https://doi.org/10.3389/fphar.2022.1029236

Source records